Patents Represented by Attorney Squires Sanders
  • Patent number: 8232294
    Abstract: The present invention provides amino ester compounds, salts, and pharmaceutical formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating inter- and/or intra-cellular signaling. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.
    Type: Grant
    Filed: March 19, 2010
    Date of Patent: July 31, 2012
    Assignees: Sunshine Lake Pharma Co., Ltd.
    Inventor: Ning Xi